Heerenveen, 5 January 2026

Pro-Vital, a leading company in the development of complex preparations, is proud to announce the acquisition of ReAge's activities. With this strategic acquisition, Pro-Vital is taking an important step in expanding its range and strengthening its position in the nutritional supplements market.

The acquisition, which was completed on 19 December 2025, marks the beginning of a new chapter for both Pro-Vital and ReAge. Pro-Vital is determined to breathe new life into ReAge's valuable ideas and to further develop the existing line of supplements aimed at supporting the ageing process.

‘ReAge has always been built on commitment and quality. In Pro-Vital, we have found a partner that shares and reinforces these values. I am proud of what we have achieved with ReAge and look forward with confidence to the future of our activities within Pro-Vital,’ said Cees de Bondt, CEO of ReAge.

Left: Cees de Bondt (Director of ReAge), Right: Wytze van der Schaaf (Director of Pro-Vital)

In the coming period, Pro-Vital will focus on completing and updating the Male Factor and Femeno product lines. In addition, every effort will be made to ensure a smooth transition of Re-Age activities.

‘At Pro-Vital, we see many opportunities and possibilities to add the excellent ReAge line of nutritional supplements to our existing Pro-Vital line,’ says Pieter Pieters, CEO of Pro-Vital. ‘This acquisition enables us to offer our customers a tailored line of high-quality products.’

Pro-Vital looks forward to the successful integration of the ReAge products and is enthusiastic about the opportunities this acquisition offers for future growth and innovation.